Recent developments in anxiety, stress, and depression

Pharmacology Biochemistry and Behavior

Volumn 54, Issue 1, 1996, Pages 3-12

  File, Sandra E ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

animal tests; anxiety; depression; glucocorticoids; immune function; stress

Indexed keywords

1 [2 (BENZHYDRYLOXY)ETHYL] 4 (3 PHENYLALLYL)PIPERAZINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; DOPAMINE UPTAKE INHIBITOR; FLUOXETINE; GLUCOCORTICOID; HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; PIRIBEDIL; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR;

AGGRESSION; ANIMAL MODEL; ANXIETY; BEHAVIOR; CHOLINERGIC SYSTEM; CONFERENCE PAPER; DEPRESSION; DOPAMINERGIC SYSTEM; HEREDITY; IMMUNITY; IMPULSIVENESS; LEARNING; MAZE TEST; NEUROTRANSMISSION; NONHUMAN; ODOR; PREDATOR; PRIORITY JOURNAL; STRESS;

EID: 0029945642     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02175-2     Document Type: Conference Paper

References (156)

1. 1A subtype receptor in the neonatal organization of agonistic behaviour in the rat. Pharmacol. Biochem. Behav. 54(1):189-193; 1996.
2. Alleva, E.; Petruzzi, S.; Cirulli, F.; Aloe, L. NGF regulatory role in stress and coping of rodents and humans. Pharmacol. Biochem. Behav. 54(1):65-72; 1996.
3. 1A receptors in the median raphé nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively. Eur. J. Pharmacol. 264:259-264; 1994.
4. Artigas, F.; Perez, V.; Alvarez, E. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch. Gen. Psychiatry 51:248-251; 1994.
5. Aue, D. Konfrontationen zwischen männlichen spitzhörnchen (Tupaia belangeri). Konsequenzen der sozialkontakte für verhalten und physiologie sowie der einfluss individueller und äusserer faktoren auf die dominanzentscheidung. Thesis, Göttingen; 1988.
6. Baldwin, H. A.; Rassnick, S.; Rivier, J.; Koob, G. F.; Britton, K. T. CRF antagonist reverses the 'anxiogenic' responses to ethanol withdrawal in the rat. Psychopharmacology (Berlin) 103: 227-232; 1991.
7. Barbaccia, M. L.; Roscetti, G.; Bolacchi, F.; Concas, A.; Mostallino, M. C.; Purdy, R. H.; Biggio, G. Stress induced increase in brain neuroactive steroids: Antagonism by abecarnil. Pharmacol. Biochem. Behav. 54(1):205-210; 1996.
8. 1A antagonist (+)-WAY-100135 on murine social and agonistic behaviour. Pharmacol. Biochem. Behav. 54(1):159-167; 1996.
9. Belzung, C.; Le Pape, G. Comparison of different behavioral test situations used in psychopharmacology for measurement of anxiety. Physiol. Behav. 56:623-628; 1994.
10. Beuzen, A.; Belzung, C. Link between emotional memory and anxiety states: A study by principal component analysis. Physiol. Behav. 58:111-118; 1995.
11. Bhatnagar, S.; Smythe, J. W.; Meaney, M. J. Hippocampal cholinergic blockade elevates stress-induced corticosterone (CORT) secretion. Soc. Neurosci. Abstr. 20:935; 1994.
12. 1A receptor ligands in the mouse. Br. J. Pharmacol. 111:151P; 1994.
13. A receptor. Brain Res. 561:157-161; 1991.
14. Blanchard, R. J.; Blanchard, D. C.; Rodgers, J.; Weiss, S. M. The characterization and modelling of antipredator defensive behavior. Neurosci. Biobehav. Rev. 14:463-472; 1990.
15. Blanchard, R. J.; Blanchard, D. C.; Weiss, S. M.; Meyer, S. The effects of ethanol and diazepam on reactions to predatory odours. Pharmacol. Biochem. Behav. 35:775-780; 1990.
16. Blanchard, D. C.; Hori, K.; Rodgers, R. J.; Hendrie, C. A.; Blanchard, R. J. Attenuation of defensive threat and attack in wild rats (Rattus rattus) by benzodiazepines. Psychopharmacology (Berlin) 97:392-401; 1989.
17. Britton, K. T.; McLeod, S.; Koob, G. F.; Hauger, R. Pregnane steroid alphaxalone attentuates anxiogenic behavioral effects of corticotropin releasing factor and stress. Pharmacol. Biochem. Behav. 41:399-403; 1992.
18. Buckingham, J. C.; Loxley, H. D.; Christian, H. C.; Philip, J. G. Activation of the HPA axis by immune insults: Roles and interactions of cytokines, eicosanoids and glucocorticoids. Pharmacol. Biochem. Behav. 54(1):285-298; 1996.
19. Cabib, S.; Puglisi-Allegra, S. Opposite responses of mesolimbic dopamine system to controllable and uncontrollable aversive experiences. J. Neurosci. 14:3333-3340; 1994.
20. Carli, M.; Prontera, C.; Samanin, R. Evidence that central 5-hydroxytryptaminergic neurones are involved in the anxiolytic activity of buspirone. Br. J. Pharmacol. 96:829-836; 1989.
21. 1A receptor agonist. Psychopharmacology (Berlin) 94:84-91; 1988.
22. Cervo, L.; Grignaschi, G.; Samanin, R. 8-Hydroxy-2(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist, reduces the immobility of rats in the forced swimming test by acting on the nucleus raphé dorsalis. Eur. J. Pharmacol. 158: 53-59; 1988.
23. Charrier, D.; Thiebot, M.-H. Effects of psychotropic drugs on rat responding in an operant paradigm involving choice between delayed reinforcers. Pharmacol. Biochem. Behav. 54(1): 149-157; 1996.
24. Cirulli, F.; Terranova, M. L.; Laviola, G. Affiliation in periadolescent rats: Behavioural and corticosterone response to social reunion with familiar or unfamiliar partners. Pharmacol. Biochem. Behav. 54(1):99-105; 1996.
25. Cohen, E.; Keshet, G.; Shavit, Y.; Weinstock, M. Prenatal naltrexone facilitates male sexual behavior in the rat. Pharmacol. Biochem. Behav. 54(1):183-188; 1996.
26. De Boer, S. F.; Slangen, J. L.; van der Gugten, J. Effects of chlordiazepoxide and buspirone on plasma catecholamine and corticosterone levels in rats under basal and stress conditions. Endocrinol. Exp. 24:229-239; 1990.
27. De Boer, S. F.; Slangen, J. L.; van der Gugten, J. Plasma catecholamine and corticosterone levels during active and passive shock-prod avoidance behavior in rats: Effects of chlordiazepoxide. Physiol. Behav. 47:1089-1098; 1990.
28. 2 receptors in depression measured with single photon emission computed tomography. Biol. Psychiatry 35:128-132: 1994.
29. Dunn, A. J. Stress-related activation of cerebral dopaminergic systems. Ann. NY Acad. Sci. 537:188-205; 1988.
30. Dunn, A. J.; Berridge, C. W. Physiological and behavioral responses to corticotropin-releasing factor administration: Is CRF a mediator of anxiety or stress responses? Brain Res. Rev. 15: 71-100; 1990.
31. Dunn, A. J.; File, S. E. Corticotropin-releasing factor has an anxiogenic action in the social interaction test. Horm. Behav. 21:193-202; 1987.
32. Dunn, R. W.; Flanagan, D. M.; Martin, L. L.; Kerman, L. L.; Woods, A. T.; Camacho, F.; Wilmot, C. A.; Cornfeldt, M. L.; Effland, R. C.; Wood, P. L.; Corbett, R. Stereoselective R-(+)enantiomer of HA-966 displays anxiolytic effects in rodents. Eur. J. Pharmacol. 214:207-214; 1992.
33. Duterte-Boucher, D.; Leclere, J.-F.; Panissaud, C.; Costentin, J. Acute effects of direct dopamine agonists in the mouse behavioral despair test. Eur. J. Pharmacol. 154:185-190; 1988.
34. Ebenezer, I. S.; Parrott, R. F.; Goode, J. The effects of intracerebroventricular (ICV) administration of pentagstrin on feeding and cortisol release in sheep. Br. J. Pharmacol. 108:286P; 1993.
35. 2 on feeding and cortisol release in pigs. Pharmacol. Biochem. Behav. 54(1):255-259; 1996.
36. Fernandes, C.; File, S. E. The influence of open arm ledges and maze experience in the elevated plus-maze. Pharmacol. Biochem. Behav. 54(1):31-40; 1996.
37. File, S. E. The ontogeny of exploration in the rat: Habituation and effects of handling. Dev. Psychobiol. 11:321-328; 1978.
38. File, S. E. Effects of a piperazine derivative, piribedil, on exploration, locomotor activity and social behaviour. Prog. Neuropsychopharmacol. 5:245-255; 1981.
39. File, S. E. Interactions of anxiolytic and antidepressant drugs with hormones of the hypothalamic-pituitary-adrenal axis. In: File, S. E., ed. Psychopharmacology of anxiolytics and antidepressants. New York: Pergamon Press; 1991:29-55.
40. File, S. E. The biological basis of anxiety. In: Meltzer, H. Y.; Nerozzi, D., eds. Current practices and future developments in the pharmacotherapy of mental disorders. Amsterdam: Elsevier Science; 1991:159-165.
41. File, S. E. The interplay of learning and anxiety in the elevated plus-maze. Behav. Brain Res. 58:199-202; 1993.
42. 1A receptor ligands in dorsal raphé and ventral hippocampus. Pharmacol. Biochem. Behav. 54(1):123-128; 1996.
43. File, S. E.; Hyde, J. R. G.; Macleod, N. K. 5,7-Dihydroxytryptamine lesions of dorsal and median raphé nuclei and performance in the social interaction test of anxiety and in a home-cage aggression test. J. Affect. Dis. 1:115-122; 1979.
44. File, S. E.; Mabbutt, P. S.; Hitchcott, P. K. Characterisation of the phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze. Psychopharmacology (Berlin) 102:98-101; 1990.
45. File, S. E.; Pellow, S. The effects of putative anxiolytic compounds (PK 8165, PK 9084 and tracazolate) on the rat corticosterone response. Physiol. Behav. 35:583-586; 1985.
46. File, S. E.; Plotkin, H. C. Habituation in the neonatal rat. Dev. Psychobiol. 7:121-127; 1974.
47. File, S. E.; Pope, J. H. Social interaction between drugged and undrugged rats. Anim. Learn. Behav. 2:161-164; 1974.
48. File, S. E.; Vellucci, S. V. Studies on the role of ACTH and 5-HT in anxiety using an animal model. J. Pharm. Pharmacol. 30:105-110; 1978.
49. File, S. E.; Vellucci, S. V.; Wendlandt, S. Corticosterone - An anxiogenic or an anxiolytic agent. J. Pharm. Pharmacol. 31: 300-305; 1979.
50. File, S. E.; Zangrossi, H., Jr.; Andrews, N. Novel environment and cat odor change GABA and 5-HT release and uptake in the rat. Pharmacol. Biochem. Behav. 45:931-934; 1993.
51. File, S. E.; Zangrossi, H., Jr.; Sanders, F. L.; Mabbutt, P. S. Dissociation between behavioral and corticosterone responses on repeated exposures to cat odor. Physiol. Behav. 54:1109-1111; 1993.
52. File, S. E.; Zangrossi, H., Jr.; Viana, M.; Graeff, F. G. Trial 2 in the elevated plus-maze: A different form of fear. Psychopharmacology (Berlin) 111:491-494; 1993.
53. Fletcher, P. A comparison of the effects of dorsal or median raphé injections of 8-OH-DPAT in three operant tasks measuring response inhibition. Behav. Brain Res. 54:187-197; 1993.
54. Fluck, E.; Hogg, S.; Mabbutt, P. S.; File, S. E. Behavioural and neurochemical responses of male and female chicks to cat odor. Pharmacol. Biochem. Behav. 54(1):85-91; 1996.
55. 1A receptors under psychosocial stress. J. Neurosci. (in press).
56. 3H]rauwolscine binding sites in the brains of male tree shrews are related to social status. Brain Res. 597:131-137; 1992.
57. Fuchs, E. Activity of the sympatho-adrenomedullary system in male (Tupaia belangeri) under control and stress situations. In: Usdin, E.; Kvetnansky, R.; Axelord, J., eds. Stress - The role of catecholamines and other neurotransmitters. Vol. 1. London: Gordon and Breach; 1984:595-602.
58. Fuchs, E.; Flügge, G. Modulation of binding sites for corticotropin-releasing hormone by chronic psychosocial sress. Psychoneuroendocrinology 20:33-51; 1994.
59. Fuchs, E.; Jöhren, O.; Flügge, G. Psychosocial conflict in the tree shrew. Effects on sympathoadrenal activity and blood pressure. Psychoneuroendocrinology 18:557-565; 1993.
60. Fuchs, E.; Kramer, M.; Hermes, B.; Netter, P.; Hiemke, C. Psychosocial stress in tree shrews: Clomipramine counteracts behavioural and endocrine changes. Pharmacol. Biochem. Behav. 54(1):219-228; 1996.
61. Fuchs, E.; Schumacher, M. Psychosocial stress affects pineal function in the tree shrew (Tupaia belangen). Physiol. Behav. 47:713-717; 1990.
62. Geoffroy, M.; Christensen, A. V. Psychomotor stimulants vs. antidepressants in the learned helplessness model of depression. Drug Dev. Res. 29:48-55; 1993.
63. Gentsch, C.; Lichtsteiner, M.; Feer, H. Competition for sucrose-pellets in triads of male Wistar rats: Effects of acute and chronic chlordiazepoxide. Psychopharmacology (Berlin) 100: 530-534; 1990.
64. 1A subsystems on adult behaviour in the rat. Pharmacol. Biochem. Behav. 54(1):189-193; 1996.
65. Gorka, Z.; Moryl, E.; Papp, M. The effect of chronic mild stress on circadian rhythms in the locomotor activity in rats. Pharmacol. Biochem. Behav. 54(1):229-234; 1996.
66. Graeff, F. G.; Guimaraes, F. S.; De Andrade, T. G. C. S.; Deakin, J. F. W. Role of 5-HT in stress, anxiety and depression. Pharmacol. Biochem. Behav. 54(1):129-141; 1996.
67. Grahn, R. E.; Kalman, B. A.; Brennan, F. X.; Watkins, L. R.; Maier, S. F. The elevated plus-maze is not sensitive to the effect of stressor controllability in rats. Pharmacol. Biochem. Behav. 52:565-570; 1995.
68. Groenink, L.; van der Gugten, J.; van der Heyden, J. A. M.; Zethof, T. J. J.; Olivier, B. Neuroendocrine effects of diazepam and flesinoxan in the stress-induced hyperthermia test in mice. Pharmacol. Biochem. Behav. 54(1):249-253; 1996.
69. Guimaraes, F. S.; Carobrez, A. P.; De Aguiar, J. C.; Graeff, F. G. Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal grey. Psychopharmacology (Berlin) 103:91-94; 1991.
70. Heinrichs, S. C.; Pich, E. M.; Miczek, K. A.; Britton, K. T.; Koob, G. F. Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action. Brain Res. 581:190-197; 1992.
71. Hendrie, C. A.; Weiss, S. M.; Eilam, D. Exploration and predation models of anxiety: A consideration of the role of the distance-dependent-defence-hierarchy using evidence from laboratory and wild species. Pharmacol. Biochem. Behav. 54(1):13-20; 1996.
72. 1-like and GABA receptors in the dorsal raphé nucleus of the rat. Neuropharmacology 27:993-1001; 1988.
73. Hodges, H.; Green, S.; Glenn, B. Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not on discrimination. Psychopharmacology (Berlin) 92:491-504; 1987.
74. Hogg, S. Validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol. Biochem. Behav. 54(1): 21-30; 1996.
75. Hogg, S.; Andrews, N.; File, S. E. Contrasting behavioural effects of 8-OH-DPAT in the dorsal raphé nucleus and ventral hippocampus. Neuropharmacology 33:343-348; 1994.
76. Hogg, S.; File, S. E. Regional differences in rat benzodiazepine binding in response to novelty and cat odor. Neuropharmacology 33:865-868; 1994.
77. Hogg, S.; File, S. E. Responders and nonresponders to cat odor do not differ in other tests of anxiety. Pharmacol. Biochem. Behav. 49:219-222; 1994.
78. Hogg, S.; Mills, A. D.; File, S. E. Differences in benzodiazepine binding in quail selectively bred for differences in tonic immobility. Pharmacol. Biochem. Behav. 54(1):117-121; 1996.
79. Hogg, S.; Paterson, S.; Mills, A. D.; File, S. E. Receptor binding in Japanese quail selected for long or short tonic immobility. Pharmacol. Biochem. Behav. 49:625-628; 1994.
80. Hutson, P. H.; Sarna, G. S.; O'Connell, M. T.; Curzon, G. Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OH-DPAT into the nucleus raphé dorsalis. Neurosci. Lett. 100:276-280; 1989.
81. 1A receptors in the effects of acute and chronic treatment with fluoxetine on extracellular concentrations of serotonin in the frontal cortex of rats. Pharmacol. Biochem. Behav. 54(1): 143-147; 1996.
82. Itoh, J.; Nabeshima, T.; Kameyama, T. Utility of an elevated plus-maze for the evaluation of memory in mice: Effects of nootropics, scopolamine and electroconvulsive shock. Psychopharmacology (Berlin) 101:27-33; 1990.
83. Johnston, A. L.; File, S. E. Can animal tests of anxiety detect panic-promoting agents? Hum. Psychopharmacol. 3:149-152; 1988.
84. Johnston, A. L.; File, S. E. Effects of ligands for specific 5-HT receptor subtypes in two animal tests of anxiety. In: Lader, M., ed. Buspirone: A new introduction to the treatment of anxiety. London: Royal Society of Medicine Service; 1988:31-41.
85. Jöhren, O.; Flügge, G.; Fuchs, E. Hippocampal glucocorticoid receptor expression in the tree shrew: Regulation by psychosocial conflict. Cell. Mol. Neurobiol. 14:281-296; 1994.
86. 1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat? J. Pharmacol. Exp. Ther. 272: 920-929; 1995.
87. Joly, D.; Sanger, D. J. Social competition in rats a test sensitive to acutely administered anxiolytics. Behav. Pharmacol. 2:205-213; 1991.
88. Kinsley, C. H.; Mann, F. E.; Bridges, R. S. Diminished luteinizing hormone release in prenatally stressed male rats after exposure to sexually receptive females. Physiol. Behav. 52:925-928; 1992.
89. 1A receptor-mediated effects of buspirone, gepirone and ipsapirone. Pharmacol. Biochem. Behav. 29:711-715; 1988.
90. Korte, S. M.; De Boer, S. F.; De Kloet, E. R.; Bohus, B. Anxiolytic-like effects of selective mineralocorticoid and glucocorticoid antagonists on fear-enhanced behavior in the elevated plusmaze. Psychoneuroendocrinology 20:385-394; 1995.
91. Korte, S. M.; Korte-Bouws, G. A. H.; Koob, G. F.; De Kloet, E. R.; Bohus, B. Mineralocorticoid and glucocorticoid receptor antagonists in animal models of anxiety. Pharmacol. Biochem. Behav. 54(1):261-267; 1996.
92. Krsiak, M.; Sulcova, A.; Donatp, P.; Tomasikova, Z.; Dlohozkova, N.; Kosar, E.; Masek, K. Can social and agonistic interactions be used to detect anxiolytic activity of drugs? In: Miczek, K. A.; Kruk, M. R.; Olivier, B., eds. Ethopharmacolgoical aggression research. New York: A. R. Liss; 1984:93-114.
93. Krsiak, M.; Sulcova, A.; Tomasikova, Z.; Dlohozkova, N.; Kosar, E.; Masek, K. Drug effects on attack, defense and escape in mice. Pharmacol. Biochem. Behav. 14(Suppl. 1):47-52; 1981.
94. Large, T. H.; Bodary, S. C.; Clegg, D. O.; Weskamp, G.; Otten, U.; Reichardt, L. F. Nerve growth factor gene expression in the developing rat brain. Science 234:352-355; 1986.
95. Le Fur, G.; Guilloux, F.; Mitrani, N.; Mizoule, J.; Uzan, A. Relationships between plasma corticosteroids and benzodiazepines in stress. J. Pharmacol. Exp. Ther. 211:305-308; 1979.
96. Leonard, B. E.; Song, C. Stress and the immune system in the aetiology of anxiety and depression. Pharmacol. Biochem. Behav. 54(1):299-303; 1996.
97. Leposavic, G.; Karapetrovic, B.; Obradovic, S.; Vidic Dankovic, B.; Kosec, D. Different effects of gonadectomy on the thymocyte phenotypic profile in the male and female rats. Pharmacol. Biochem. Behav. 54(1):269-276; 1996.
98. Logue, A. W. Research on self-control: An integrated framework. Behav. Brain Sci. 11:665-709; 1988.
99. Lowry, P. J.; Woods, R. J.; Baigent, S. Corticotropin releasing factor and its binding protein. Pharmacol. Biochem. Behav. 54(1):305-308; 1996.
100. McNaughton, N.; Coop, C. F. Neurochemically dissimilar anxiolytic drugs have common effects on hippocampal rhythmic slow activity. Neuropharmacology 30:855-863; 1991.
101. McNaughton, N.; Panickar, K. S.; Logan, B. The pituitary-adrenal axis and the different behavioural effects of buspirone and chlordiazepoxide. Pharmacol. Biochem. Behav. 54(1):51-56; 1996.
102. Maier, S. F.; Grahn, R. E.; Kalman, B. A.; Sutton, L. C.; Wiertelak, E. P.; Watkins, L. R. The role of amygdala and dorsal raphé nucleus in mediating the behavioural consequences of inescapable shock. Behav. Neurosci. 107:377-388; 1993.
103. Maier, S. F.; Grahn, R. E.; Watkins, L. R. 8-OH-DPAT microinjected in the region of the dorsal raphé nucleus blocks and reverses the enhancement of fear conditioning and interference with escape produced by exposure to inescapable shock. Behav. Neurosci. 109:404-412; 1995.
104. Marotti, T.; Gabrilovac, J.; Rabatic, S.; Smejkal-Jagar, L.; Rocic, B.; Haberstock, H. Met-enkephalin modulates stress-induced alterations of the immune response in mice. Pharmacol. Biochem. Behav. 54(1):277-283; 1996.
105. Mitchell, P. J.; Redfern, P. H. Chronic treatment with clomipramine and mianserin increases the hierarchical position of subdominant rats housed in triads. Behav. Pharmacol. 3:239-247; 1992.
106. Montefrancesco, G.; Giorgi, G.; Dal Pra, P.; Micheli, L.; Segre, G. Plasma ACTH levels in buspirone-treated rats. Arch. Int. Pharmacodyn. 305:183-188; 1990.
107. Mouret, J.; Lemoine, P.; Minuit, M. P. Marqueurs polygraphiques, cliniques et thérapeutiques des dépressions dopamine dépendantes. C. R. Acad. Sci. Paris 305:301-306; 1987.
108. Murphy, D. L.; Lesch, K. P.; Aulakh, C. S.; Pigott, T. A. Serotonin-selective arylpiperazines with neuroendocrine, behavioural, temperature, and cardiovascular effects in humans. Pharmacol. Rev. 43:527-552; 1991.
109. Nemeroff, C. B. The role of corticotropin-releasing factor in the pathogenesis of major depression. Pharmacopsychiatry 21:76-82; 1988.
110. New, J. S. The discovery and development of buspirone: A new approach to the treatment of anxiety. Med. Res. Rev. 10:283-326; 1990.
111. Owens, M. J.; Vargas, M. A.; Nemeroff, C. B. The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: Implications for a role for CRF in the pathogenesis of anxiety disorders. J. Psychiatr. Res. 27:209-222; 1993.
112. Palanza, P.; Rodgers, R. J.; Ferrari, P. F.; Parmigiani, S. Effects of chlordiazepoxide on maternal aggression in mice depend upon experience of resident and sex of intruder. Pharmacol. Biochem. Behav. 54(1): 175-182; 1996.
113. Parmigiani, S.; Palanza, P.; Brain, P. F. Intraspecific maternal aggression in the house mouse (Mus domesticus): A counterstrategy to infanticide by male? Ethol. Ecol. Evol. 1:341-352; 1989.
114. Parmigiani, S.; Rodgers, R. J.; Palanza, P.; Mainardi, M.; Brain, P. F. The inhibitory effects of fluprazine on parental aggression in female mice are dependent upon intruder sex. Physiol. Behav. 46:455-459; 1989.
115. Parrott, R. F. Peripheral and central effects of CCK receptor agonists on operant feeding in pigs. Physiol. Behav. 53:367-372; 1993.
116. Parrott, R. F.; Ebenezer, I. S.; Baldwin, B. A.; Forsling, M. L. Central and peripheral doses of cholecystokinin that inhibit feeding in pigs also stimulate vasopressin and cortisol release. Exp. Physiol. 76:525-531; 1991.
117. Paul, S. M.; Purdy, R. H. Neuroactive steroids. FASEB J. 6: 2311-2320; 1991.
118. Plaznik, A.; Palejko, W.; Nazar, M.; Jessa, M. Effects of antagonists at the NMDA receptor complex in two models of anxiety. Eur. Neuropsychopharmacol. 4:503-512; 1994.
119. Pletnikov, M. V.; Storozheva, Z. I.; Sherstnev, V. V. Relationship between memory and fear: Developmental and pharmacological studies. Pharmacol. Biochem. Behav. 54(1):93-98; 1996.
120. Post, R. M.; Gerner, R. H.; Carman, J. S.; Gillin, J. C.; Jimerson, D. C.; Goodwin, F. K.; Bunney, W. E. Effects of a dopamine agonist piribedil in depressed patients. Arch. Gen. Psychiatry 35:609-615; 1978.
121. Przegalinski, E.; Tatarczynska, E.; Deren-Wesolek, A.; Chojnacka-Wojcik, E. Anticonflict effects of a competitive NMDA receptor antagonist and a partial agonist at strychnine-insensitive glycine receptors. Pharmacol. Biochem. Behav. 54(1):73-77; 1996.
122. A receptors. Neuron 4:759-765; 1990.
123. Rassnick, S.; Heinrichs, S. C.; Britton, K. T.; Koob, G. F. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res. 605:25-32; 1993.
124. Rex, A.; Sondern, U.; Voigt, J. P.; Franck, S.; Fink, H. Strain differences in fear motivated behaviour of rats. Pharmacol. Biochem. Behav. 54(1):107-111; 1996.
125. Rickels, K.; Schweizer, E. E. Current pharmacotherapy of anxiety and panic. In: Meltzer, H. Y., ed. Psychopharmacology: The third generation of progress. New York: Raven Press; 1987: 1193-1203.
126. 3 antagonists and benzodiazepines. Their comparative behavioural pharmacology. Chichester: John Wiley & Sons Ltd.; 1991:195-231.
127. Rodgers, R. J.; Cole, J. C. Anxiety enhancement in the murine elevated plus-maze by immediate prior exposure to social stressors. Physiol. Behav. 53:383-388; 1993.
128. 1A receptor antagonist, in the murine elevated plus-maze. Eur. J. Pharmacol. 261:321-325; 1994.
129. Rodgers, R. J.; Cole, J. C. Effects of scopolamine and its quaternary analogue in the murine elevated plus-maze test of anxiety. Behav. Pharmacol. 6:283-289; 1995.
130. 3 receptor agonist, 7-OH-DPAT. Pharmacol. Biochem. Behav. 54(1):41-50; 1996.
131. Rodgers, R. J.; Johnson, N. J. T.; Cole, J. C.; Dewar, C. V.; Kidd, G. R.; Kimpson, P. H. Plus-maze retest profile: Importance of initial stages of trial 1 and response to posttrial cholinergic receptor blockade. Pharmacol. Biochem. Behav. 54(1):79-84; 1996.
132. Rodgers, R. J.; Lee, C.; Shepherd, J. K. Effects of diazepam on behavioural and antinociceptive responses to the elevated plusmaze in male mice depend upon treatment regimen and prior maze experience. Psychopharmacology (Berlin) 106:102-110; 1992.
133. 1A receptor agonists 8-OH-DPAT, ipsapirone and buspirone in the rat. Eur. J. Pharmacol. 249:341-351; 1993.
134. 1A receptor agonists 8-OH-DPAT and ipsapirone in the rat forced swimming test. Behav. Pharmacol. 4:625-636; 1993.
135. Salminen, O.; Lahtinen, S.; Ahtee, L. Expression of Fos protein in various rat brain areas following acute nicotine and diazepam. Pharmacol. Biochem. Behav. 54(1):241-248; 1996.
136. Sharp, T.; Bramwell, S. R.; Clark, D.; Grahame-Smith, D. G. In vivo measurement of extracellular 5-hydroxytryptamine in hippocampus of the anaesthetized rat using microdialysis: Changes in relation to 5-hydroxytryptaminergic neuronal activity. J. Neurochem. 53:234-240; 1990.
137. Short, K. R.; Maier, S. F. Stressor controllability, social interaction, and benzodiazepine systems. Pharmacol. Biochem. Behav. 45:827-883; 1993.
138. Sluyter, F.; Korte, S. M.; Bohus, B.; van Oortmerssen, G. A. Behavioral stress response of genetically selected aggressive and nonaggressive wild house mice in the shock-probe/defensive burying test. Pharmacol. Biochem. Behav. 54(1):113-116; 1996.
139. Smythe, J. W.; Murphy, D.; Bhatnagar, S.; Timothy, C.; Costall, B. Muscarinic antagonists are anxiogenic in rats tested in the black-white box. Pharmacol. Biochem. Behav. 54(1):57-63; 1996.
140. Stanford, S. C. Stress: A major variable in the psychopharmacological response. Pharmacol. Biochem. Behav. 54(1):211-217; 1996.
141. Swerdlow, N. R.; Geyer, M. A.; Vale, W. W.; Koob, G. F. Corticotropin-releasing factor potentiates acoustic startle in rats: Blockade by chlordiazepoxide. Psychopharmacology (Berlin) 88:147-152;1986.
142. Takahashi, L. K.; Kalin, N. H.; Baker, E. W. Corticotropin-releasing factor antagonist attenuates defensive-withdrawal behavior elicited by odors of stressed conspecifics. Behav. Neurosci. 104:386-389; 1990.
143. Taylor, D. P.; Riblet, L. A.; Stanton, H. C. Dopamine and anxiolytics. In: Malick, J. B.; Enna, S. J.; Yamamura, H. I., eds. Anxiolytics: Neurochemical, behavioral and clinical perspectives. New York: Raven Press; 1983:77-71.
144. Thiébot, M.-H.; Bihand, C.; Soubrié, P.; Simon, P. Benzodiazepines reduce the tolerance to reward delay in rats. Psychopharmacology (Berlin) 86:147-152; 1985.
145. 3 antagonists and benzodiazepines. Their comparative behavioural pharmacology. Chichester: John Wiley & Sons Ltd.; 1991:151-194.
146. Tunnicliff, G. Molecular basis of buspirone's anxiolytic action. Pharmacol. Toxicol. 69:149-156; 1991.
147. Vaugeois, J.-M.; Pouhé, D.; Zuccaro, F.; Costentin, J. Indirect dopamine agonists effects on despair test: Dissociation from hyperactivity. Pharmacol. Biochem. Behav. 54(1):235-239; 1996.
148. Vellucci, S. V. Primate social behavior - Anxiety or depression? In: File, S. E., ed. Psychopharmacology of anxiolytics and anti-depressants. New York: Pergamon Press; 1991:83-105.
149. Von Holst, D.; Fuchs, E.; Stöhr, W. Physiological changes in male Tupaia belangen under different types of social stress. In: Dembroski, T. M.; Schmidt, T. H.; Blümchen, G., eds. Biobehavioral bases of coronary heart disease. Basel: Karger; 1983: 382-390.
150. Ward, I. L. Prenatal stress feminizes and demasculinizes the behavior of males. Science 175:82-84; 1972.
151. Wehr, T. A.; Wirz-Justice, A. Circadian rhythm mechanisms in affective illness and in antidepressant drug action. Pharmacopsychiatria 15:31-39; 1982.
152. Willner, P.; Muscat, R.; Papp, M. Chronic mild stress-induced anhedonia: A realistic animal model of depression. Neurosci. Biobehav. Rev. 16:525-534; 1992.
153. Wirz-Justice, A.; Campbell, I. C. Antidepressant drugs can slow or dissociate circadian rhythms. Experientia 38:1301-1309; 1982.
154. Wollnik, F. Effects of chronic administration and withdrawal of antidepressant agents on circadian activity rhythms in rats. Pharmacol. Biochem. Behav. 43:549-561; 1992.
155. Woodall, K. L.; Domeney, A. M.; Kelly, M. E. The selective effect of 8-OH-DPAT on social competition in the rat. Pharmacol. Biochem. Behav. 54(1):169-173; 1996.
156. Zangrossi, H., Jr.; File, S. E. Chlordiazepoxide reduces the generalised anxiety, but not the direct responses, of rats exposed to cat odor. Pharmacol. Biochem. Behav. 43:1195-1200; 1992.